Author

Yangbing Zhao

UTC Therapeutics IncPrimary ORCID profile (0000-0003-3041-2535 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yangbing ZhaoiD1 paper · Abramson Cancer Center

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

C. Han· 1 shared F. Yang· 1 shared G. Zhu· 1 shared J. Feng· 1 shared J. Wang· 1 shared X. Liu· 1 shared Z. Zi· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Han

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual CD40/CD28 co-stimulation reprograms the solid-tumor microenvironment to unleash CAR-T and endogenous anti-tumor immunity

Z. Zi, J. Feng, C. Han, F. Yang, J. Wang, G. Zhu, X. Liu, Yangbing Zhao

This paper introduces LACO-Stim, a co-stimulatory molecule that enhances CAR-T cell therapy by reprogramming the tumor microenvironment to support endogenous anti-tumor immunity.

bioRxiv · Nov 10, 2026 · PreprintImmunology